Osteopontin: a potentially important therapeutic target in cancer
Authors:
- Reeti BeheraRBReeti Behera
- Goutam ChakrabortyGCGoutam Chakraborty
- Shalini JainSJShalini Jain
- Vinit KumarVKVinit Kumar
- Priyanka SharmaPSPriyanka Sharma
- Anuradha BulbuleABAnuradha Bulbule
- Smita KaleSKSmita Kale
- Santosh KumarSKSantosh Kumar
- Rosalin MishraRMRosalin Mishra
- Remya RajaRRRemya Raja
- Supriya SaraswatiSSSupriya Saraswati
- 24 May 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 15 (9) , 1113-1126
Abstract
(2011). Osteopontin: a potentially important therapeutic target in cancer. Expert Opinion on Therapeutic Targets: Vol. 15, No. 9, pp. 1113-1126. doi: 10.1517/14728222.2011.594438Keywords
This publication has 90 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell linesSurgery, 2010
- Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneityThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Osteopontin induces β-catenin signaling through activation of Akt in prostate cancer cellsExperimental Cell Research, 2010
- RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer CellsMolecular Therapy, 2009
- Osteopontin‐c is a selective marker of breast cancerInternational Journal of Cancer, 2007
- Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesHuman Pathology, 2006
- Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435Clinical & Experimental Metastasis, 2006
- Prognostic significance of osteopontin expression in human prostate cancerInternational Journal of Cancer, 2005
- The Hallmarks of CancerCell, 2000